Public deck

Danaher: life-science quality has to show up in bioprocess recovery and cash conversion

Danaher reported 2025 revenue of $24.57 billion and Q1 2026 revenue of $5.95 billion. The thesis depends on bioprocess recovery, diagnostics demand, operating leverage, acquisitions and cash conversion.